MENU
PTH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

PTH stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index")... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
PTH
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for PTH with price predictions
Oct 22, 2026

PTH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PTH turned positive on October 21, 2026. Looking at past instances where PTH's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on PTH as a result. In 78 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

Following a +4.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTH advanced for three days, in 276 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

PTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

PTH moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PTH crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for PTH entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Exelixis (NASDAQ:EXEL).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.

Market Cap

The average market capitalization across the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF is 28.39B. The market cap for tickers in the group ranges from 915.13M to 57.86B. NTRA holds the highest valuation in this group at 57.86B. The lowest valued company is ANRO at 915.13M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF was 1%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was 13%. PLSE experienced the highest price growth at 16%, while TWST experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF was -0%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 50
Price Growth Rating: 46
SMR Rating: 75
Profit Risk Rating: 69
Seasonality Score: 22 (-100 ... +100)
PTH's MACD Histogram just turned positive